According to Tandem Diabetes Care 's latest financial reports the company's current earnings (TTM) are -$0.23 B. In 2022 the company made an earning of -$92.86 M a decrease over its 2021 earnings that were of $15.9 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.23 B | 137.21% |
2022 | -$92.86 M | -683.94% |
2021 | $15.9 M | -143.83% |
2020 | -$36.29 M | 47.46% |
2019 | -$24.61 M | -79.92% |
2018 | -$0.13 B | 67.83% |
2017 | -$73.03 M | -12.5% |
2016 | -$83.47 M | 15.27% |
2015 | -$72.41 M | -8.87% |
2014 | -$79.46 M | 25.84% |
2013 | -$63.14 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -7,805.65% | ๐บ๐ธ USA |
Medtronic MDT | $6.23 B | -2,930.82% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | $24.42 M | -111.09% | ๐บ๐ธ USA |
DexCom DXCM | $0.79 B | -462.63% | ๐บ๐ธ USA |
Insulet PODD | $0.24 B | -212.82% | ๐บ๐ธ USA |